Clinical Trials Directory

Trials / Conditions / Diffuse Large Cell Lymphoma

Diffuse Large Cell Lymphoma

25 registered clinical trials studyying Diffuse Large Cell Lymphoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingPomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
NCT05389423
National Cancer Institute (NCI)Phase 1
Active Not RecruitingOptimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy
NCT04745559
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
UnknownCAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
NCT02819583
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
UnknownPCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia a
NCT02892695
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
UnknownStudy Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymp
NCT02851589
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
CompletedPilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relaps
NCT02374333
University of PennsylvaniaPhase 1
CompletedSafety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
NCT01943682
Children's Hospital Medical Center, CincinnatiPhase 1
TerminatedStudy of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma
NCT01685606
Brown UniversityPhase 2
CompletedTreatment for Advanced B-Cell Lymphoma
NCT01859819
New York Medical CollegePhase 2
CompletedAMG 319 Lymphoid Malignancy FIH
NCT01300026
AmgenPhase 1
CompletedBendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
NCT01234467
UNC Lineberger Comprehensive Cancer CenterPhase 2
CompletedObservational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patient
NCT00949741
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie—
TerminatedStudy of Repeat Intranodal Injections of Ad-ISF35
NCT00942409
Januario Castro, M.D.Phase 2
CompletedPhase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat
NCT00791011
AmgenPhase 1
CompletedZevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation
NCT00591630
M.D. Anderson Cancer CenterPhase 2
CompletedPhase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malig
NCT00275431
Ascenta TherapeuticsPhase 2
CompletedA Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
NCT00268853
CTI BioPharmaPhase 2
UnknownClinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haemat
NCT00598624
IRCCS San RaffaelePhase 2
CompletedEarly On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
NCT00286832
Copenhagen University Hospital at Herlev—
CompletedACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjuste
NCT00140595
Lymphoma Study AssociationPhase 3
CompletedACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma
NCT00144807
Lymphoma Study AssociationPhase 2
CompletedR-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lympho
NCT00144755
Lymphoma Study AssociationPhase 3
TerminatedACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
NCT00140660
Lymphoma Study AssociationPhase 3
CompletedRituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma
NCT00169195
Lymphoma Study AssociationPhase 2
CompletedRituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma
NCT00225212
Stanford UniversityPhase 2